GGrantIndex
← Leaderboards

Larry C Borish

University Of Virginia Charlottesville

$12,170,802
Attributed
$12,446,698
Total exposure
14
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $999.9K · FY200525
$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,446,698 · 14

By mechanism

R01$5,010,398 · 2
U01$3,598,935 · 1
U19$1,310,496 · 1
R21$866,470 · 2
R56$709,300 · 2
K24$487,303 · 1

Top collaborators

Others in their field

Top investigators on “Asthma

Research focus

AsthmaCytokineEosinophilSinusitisInflammatoryLeukotrienesAspirinInflammationAllergicResponseMediatingCellsHuman SubjectBaseImmuneProductionEosinophiliaSymptomsIn VivoClinical ResearchInflammatory ResponseHyperplasiaMolecularRhinovirus

Grant awards (45)

Exploring innate immune responses to rhinovirus in allergic asthma$80,750
R03 · FY2025 · AI · contact PI
Protracted clinical and inflammatory response to rhinovirus challenge in human asthmatics$323,000
R56 · FY2022 · AI · contact PI
Lung rhinovirus (RV) infection identifies pre-school children with type 2 inflammation at risk for the development of asthma$242,250
R21 · FY2021 · AI · contact PI
Clinical response to rhinovirus challenge in human asthmatics$699,799
U01 · FY2020 · AI · contact PI
Lung rhinovirus (RV) infection identifies pre-school children with type 2 inflammation at risk for the development of asthma$201,875
R21 · FY2020 · AI · contact PI
Clinical response to rhinovirus challenge in human asthmatics$699,799
U01 · FY2019 · AI · contact PI
Clinical response to rhinovirus challenge in human asthmatics$699,779
U01 · FY2018 · AI · contact PI
Clinical response to rhinovirus challenge in human asthmatics$799,779
U01 · FY2017 · AI · contact PI
Clinical response to rhinovirus challenge in human asthmatics$699,779
U01 · FY2016 · AI · contact PI
Clinical immune response to rhinovirus challenge in human asthmatics$386,300
R56 · FY2015 · AI · contact PI
Interplay between LTE4/LTE4 receptors and IFN-y with mast cells and eosinophils i$385,000
R01 · FY2015 · AI · contact PI
Interplay between LTE4/LTE4 receptors and IFN-y with mast cells and eosinophils i$385,000
R01 · FY2014 · AI · contact PI
Interplay between LTE4/LTE4 receptors and IFN-y with mast cells and eosinophils i$361,900
R01 · FY2013 · AI · contact PI
Interplay between LTE4/LTE4 receptors and IFN-y with mast cells and eosinophils i$385,000
R01 · FY2012 · AI · contact PI
Interplay between LTE4/LTE4 receptors and IFN-y with mast cells and eosinophils i$385,000
R01 · FY2011 · AI · contact PI
CD4+ and CD8+ T cell dependent immune mechanisms of rhinovirus-mediated asthma ex$114,345
R21 · FY2011 · AI · contact PI
Cysteinyl leukotrienes in chronic sinusitis and asthma$357,172
R01 · FY2010 · AI · contact PI
Impact of chronic hyperplastic eoslnophilic sinusitis on asthma$334,734
U19 · FY2010 · AI · contact PI
CD4+ and CD8+ T cell dependent immune mechanisms of rhinovirus-mediated asthma ex$308,000
R21 · FY2010 · AI · contact PI
Cysteinyl leukotrienes in chronic sinusitis and asthma$360,779
R01 · FY2009 · AI · contact PI
Impact of chronic hyperplastic eoslnophilic sinusitis on asthma$250,722
U19 · FY2009 · AI · contact PI
Cysteinyl leukotrienes in chronic sinusitis and asthma$360,779
R01 · FY2008 · AI · contact PI
Impact of chronic hyperplastic eoslnophilic sinusitis on asthma$243,409
U19 · FY2008 · AI · contact PI
Cysteinyl leukotrienes in chronic sinusitis and asthma$367,766
R01 · FY2007 · AI · contact PI
Impact of chronic hyperplastic eoslnophilic sinusitis on asthma$240,881
U19 · FY2007 · AI · contact PI
Cysteinyl leukotrienes in chronic sinusitis and asthma$379,792
R01 · FY2006 · AI · contact PI
Impact of chronic hyperplastic eoslnophilic sinusitis on asthma$240,750
U19 · FY2006 · AI · contact PI
CT SCAN AND RHINOSCOPY TO MONITOR CHRONIC HYPERPLASTIC SINUSITIS$765
M01 · FY2006 · RR · contact PI
CT SCAN AND RHINOSCOPY TO MONITOR CHRONIC HYPERPLASTIC SINUSITIS$787
M01 · FY2005 · RR
RECOMBINANT HUMAN INTERLEUKIN-4 RECEPTOR IN ASTHMA$255,482
R01 · FY2004 · AI
RECOMBINANT HUMAN INTERLEUKIN-4 RECEPTOR IN ASTHMA$257,400
R01 · FY2003 · AI
ASA DESENSITIZATION/LT MODIFIERS RHUIL-4R IN ASTHMA$129,969
K24 · FY2003 · AI
RECOMBINANT HUMAN INTERLEUKIN-4 RECEPTOR IN ASTHMA$213,408
R01 · FY2002 · AI
ASPIRIN DESENSITIZATION IN HYPERPLASTIC SINUSITIS$190,747
M01 · FY2002 · RR
ASA DESENSITIZATION/LT MODIFIERS RHUIL-4R IN ASTHMA$122,946
K24 · FY2002 · AI
Chronic hyperplastic sinusitis and asthma$0
P01 · FY2002 · AI
RECOMBINANT HUMAN INTERLEUKIN-4 RECEPTOR IN ASTHMA$258,920
R01 · FY2001 · AI
ASPIRIN DESENSITIZATION IN HYPERPLASTIC SINUSITIS$190,747
M01 · FY2001 · RR
ASA DESENSITIZATION/LT MODIFIERS RHUIL-4R IN ASTHMA$122,946
K24 · FY2001 · AI
ASPIRIN DESENSITIZATION IN HYPERPLASTIC SINUSITIS$0
M01 · FY2001 · RR
Chronic hyperplastic sinusitis and asthma$0
P01 · FY2001 · AI
RECOMBINANT HUMAN INTERLEUKIN 4 RECEPTOR IN ASTHMA$297,000
R01 · FY2000 · AI
ASA DESENSITIZATION/LT MODIFIERS RHUIL-4R IN ASTHMA$111,442
K24 · FY2000 · AI
ASPIRIN DESENSITIZATION IN HYPERPLASTIC SINUSITIS$0
M01 · FY2000 · RR
ASPIRIN DESENSITIZATION IN HYPERPLASTIC SINUSITIS$0
M01 · FY2000 · RR